Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranolol

Claudia Pföhler1, Eva Janssen, Arno Buecker

  • 1Department of Dermatology and.

Insights

The beta-blocker propranolol effectively treats infantile hemangiomas by constricting blood vessels and inhibiting growth. This case report suggests propranolol may also benefit adults with vascular malformations like Klippel-Trénaunay syndrome.

Area of Science:

  • Vascular medicine
  • Pharmacology

Background:

  • Infantile hemangiomas are successfully treated with propranolol.
  • Propranolol's mechanism involves vasoconstriction, anti-angiogenesis, and apoptosis induction.
  • The potential for propranolol in other vascular conditions is unexplored.

Observation:

  • This report details propranolol treatment for adult vascular malformations.
  • Conditions treated include Klippel-Trénaunay syndrome and Parkes-Weber syndrome.

Findings:

  • Propranolol demonstrated therapeutic effects in adult patients with complex vascular malformations.
  • The study supports extending propranolol's use beyond infantile hemangiomas.

Implications:

  • Propranolol may offer a new treatment avenue for adult vascular malformations.
  • Further research is warranted to confirm efficacy and safety in this population.